Weather for the Following Location: Lexington on Map

Cardiff Lexington Corporation Announces Third Quarter Financial Results

Healthcare professionals at Cardiff Lexington clinic

Lexington, KY, November 8, 2025

Cardiff Lexington Corporation, a healthcare holding company, is set to reveal its third quarter financial results on November 14. With a focus on niche clinics in Orthopedics, Spine Care, and Pain Management, the company’s commitment to innovation highlights the potential for growth in Lexington’s economy. The forthcoming conference call will provide insights into the company’s operational performance and community impact as it navigates a competitive market environment.

Lexington, KY – Cardiff Lexington Corporation Announces Third Quarter 2025 Financial Results and Conference Call

Lexington, KY – In a promising sign for local entrepreneurship, Cardiff Lexington Corporation is set to unveil its third quarter financial results on November 14, 2025. This small yet impactful healthcare holding company, focused on middle-market niche clinics, is reinforcing the importance of innovation in the healthcare sector and showcasing its commitment to excellence in service and operational performance.

As the health sector continues to evolve, the resilience of companies like Cardiff Lexington plays a crucial role in driving economic activity in Lexington, KY. By concentrating on Orthopedics, Spine Care, and Pain Management, Cardiff Lexington not only operates clinics across Florida and Georgia but also symbolizes the potential for local businesses to expand successfully in a competitive market environment.

Conference Call Details

Shareholders and interested stakeholders can participate in the upcoming conference call at 9:00 am Eastern Standard Time (EST) on November 14, 2025. For those in the U.S., dial (888) 506-0062; international participants can connect at (973) 528-0011, using access code 223050. Furthermore, the call will be streamed live via the company’s dedicated webcast link, allowing for broad accessibility.

About Cardiff Lexington Corporation

Established as a leading player in healthcare investment, Cardiff Lexington Corporation seeks to extend its influence in specialized clinic acquisitions and operations. Its wholly-owned subsidiary, Nova Ortho and Spine, LLC, serves as the backbone for generating revenue through a network of orthopedic care centers that cater to traumatic injury patients with a comprehensive suite of services ranging from diagnostics to surgical interventions.

The Importance of Local Investment

With a commitment to maintaining a partnership-driven culture, Cardiff Lexington exemplifies the spirit of local business innovation. This approach not only fosters teamwork and accountability but also enhances performance amid an evolving healthcare landscape. The company’s model highlights how targeted investments in specific healthcare sectors can contribute to overall economic growth and job creation, particularly in the Lexington area.

Economic Growth Opportunities

The planned conference call presents an opportunity for the community and investors to grasp the future outlook of Cardiff Lexington Corporation. The nature of its business, focusing on niche markets, reflects the broader potential for Kentucky entrepreneurs and local investors to leverage specialized knowledge in advancing their initiatives. Furthermore, as the state continues to nurture a business-friendly environment with limited regulation, the potential for entrepreneurial innovation could skyrocket.

Conclusion

As Cardiff Lexington Corporation prepares to announce its third quarter financial results, it underscores the unwavering determination of local businesses to thrive in the healthcare sector. The community can look forward to insights on the company’s performance and future ambitions, emphasizing the importance of supporting local enterprises and staying engaged with Lexington’s evolving economic landscape. As we await the conference, let’s continue to champion the innovation, resilience, and dedication that drive our local economy forward.

Frequently Asked Questions (FAQ)

What is the date and time of Cardiff Lexington Corporation’s third quarter 2025 financial results conference call?

The conference call is scheduled for Friday, November 14, 2025, at 9:00 am Eastern Standard Time (EST).

How can I participate in the conference call?

Shareholders and interested parties can participate by dialing (888) 506-0062 for U.S. participants or (973) 528-0011 for international participants, using access code: 223050. The call and the accompanying slide deck will also be webcast at https://www.webcaster5.com/Webcast/Page/3131/53160.

Where can I find the webcast and slide deck after the conference call?

An online archive of the webcast and slide deck will be available on the Investor Relations page of the company’s website following the call at https://investor.cardifflexington.com/overview/default.aspx.

How can I access the replay of the conference call?

A replay of the conference call will be available one hour after completion of the call until Friday, November 28, 2025, by dialing (877) 481-4010 for U.S. participants or (919) 882-2331 for international participants, using access code 53160.

What is the focus of Cardiff Lexington Corporation?

Cardiff Lexington Corporation is a healthcare holding company focused on acquiring and building middle-market niche healthcare clinics, primarily in Orthopedics, Spine Care, and Pain Management.

Where does Cardiff Lexington Corporation operate its healthcare facilities?

The company’s revenue is derived from Nova Ortho and Spine, LLC, which operates a network of regional specialty and ancillary orthopedic care centers across Florida and Georgia.

FAQ Schema in JSON-LD Format

{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is the date and time of Cardiff Lexington Corporation's third quarter 2025 financial results conference call?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The conference call is scheduled for Friday, November 14, 2025, at 9:00 am Eastern Standard Time (EST)."
      }
    },
    {
      "@type": "Question",
      "name": "How can I participate in the conference call?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Shareholders and interested parties can participate by dialing (888) 506-0062 for U.S. participants or (973) 528-0011 for international participants, using access code: 223050. The call and the accompanying slide deck will also be webcast at https://www.webcaster5.com/Webcast/Page/3131/53160."
      }
    },
    {
      "@type": "Question",
      "name": "Where can I find the webcast and slide deck after the conference call?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "An online archive of the webcast and slide deck will be available on the Investor Relations page of the company's website following the call at https://investor.cardifflexington.com/overview/default.aspx."
      }
    },
    {
      "@type": "Question",
      "name": "How can I access the replay of the conference call?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "A replay of the conference call will be available one hour after completion of the call until Friday, November 28, 2025, by dialing (877) 481-4010 for U.S. participants or (919) 882-2331 for international participants, using access code 53160."
      }
    },
    {
      "@type": "Question",
      "name": "What is the focus of Cardiff Lexington Corporation?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Cardiff Lexington Corporation is a healthcare holding company focused on acquiring and building middle-market niche healthcare clinics, primarily in Orthopedics, Spine Care, and Pain Management."
      }
    },
    {
      "@type": "Question",
      "name": "Where does Cardiff Lexington Corporation operate its healthcare facilities?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The company's revenue is derived from Nova Ortho and Spine, LLC, which operates a network of regional specialty and ancillary orthopedic care centers across Florida and Georgia."
      }
    }
  ]
}

Key Features of Cardiff Lexington Corporation’s Upcoming Conference Call

Feature Details
Conference Call Date and Time Friday, November 14, 2025, at 9:00 am Eastern Standard Time (EST)
Access Numbers U.S.: (888) 506-0062; International: (973) 528-0011; Access Code: 223050
Webcast Link https://www.webcaster5.com/Webcast/Page/3131/53160
Investor Relations Page https://investor.cardifflexington.com/overview/default.aspx
Replay Availability Available one hour after the call until Friday, November 28, 2025; U.S.: (877) 481-4010; International: (919) 882-2331; Access Code: 53160
Company Focus Acquiring and building middle-market niche healthcare clinics in Orthopedics, Spine Care, and Pain Management
Operating Regions Florida and Georgia

Now Happening on X

  • @CHItraders (November 6, 2025): Cardiff Oncology reported Q3 earnings with an adjusted EPS beat of -0.17, up 32% YoY, though sales of $120K were down 27% YoY. View on X
  • @CardiffLex (November 7, 2025): Cardiff Lexington will release Q3 2025 earnings results and host its earnings call on November 14 at 9 AM ET, with a press release link provided. View on X
  • @k2__investment (November 6, 2025): Despite revenue shortfall and elevated Medical Loss Ratio, EPS exceeded expectations due to effective cost management, with reaffirmed FY 2025 guidance of $12.1. View on X
  • @DollarCostAvg (November 6, 2025): Highlights EPS beat and margin improvement with EPS of -$0.53 beating estimates by 9%, narrowing losses 40% QoQ, alongside 23% YoY revenue growth. View on X
  • @gt_financial (November 6, 2025): Greentree Financial Group announced an advisory services agreement with Cardiff Lexington Corporation, a healthcare-focused holding company. View on X
  • @LawrenceEvansCo (November 3, 2025): Shared healthcare news including government shutdown impacts on ObamaCare subsidies and acquisitions like Thermo Fisher Scientific’s $8.9B deal for Clario Holdings. View on X
  • @OFNHP (November 8, 2025): Discussed Kaiser Permanente’s $12.9 billion revenue last year and CEO’s $12 million pay, emphasizing the fight for safe staffing in healthcare. View on X

Deeper Dive: News & Info About This Topic

HERE Resources

Cardiff Lexington Corporation Set to Release Financial Results

STAFF HERE LEXINGTON KY STAFF
Author: STAFF HERE LEXINGTON KY STAFF

The LEXINGTON STAFF WRITER represents the experienced team at HERELexingtonKY.com, your go-to source for actionable local news and information in Lexington, Fayette County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Woodland Art Fair, Crave Food and Music Festival, and Railbird Festival. Our coverage extends to key organizations like Commerce Lexington and Blue Grass Community Foundation, plus leading businesses in education, manufacturing, and technology that power the local economy such as University of Kentucky, Toyota Motor Manufacturing, and Lexmark. As part of the broader HERE network, including HEREBowlingGreen.com and HERELouisville.com, we provide comprehensive, credible insights into Kentucky's dynamic landscape.

ADD MORE INFORMATION OR CONTRIBUTE TO OUR ARTICLE CLICK HERE!
Advertising Opportunity:

Stay Connected

More Updates

Would You Like To Add Your Business?

Sign Up Now and get your local business listed!